These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8100209)

  • 21. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
    Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
    J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.
    Galicka A; Wołczyński S; Gindzieński A; Surazyński A; Pałka J
    Mol Cell Biochem; 2003 Jun; 248(1-2):49-56. PubMed ID: 12870654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
    Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
    J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
    Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and pro alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Castells S; Bugge M; Prockop DJ
    Hum Mutat; 1996; 7(2):89-99. PubMed ID: 8829649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
    Tsuneyoshi T; Westerhausen A; Constantinou CD; Prockop DJ
    J Biol Chem; 1991 Aug; 266(24):15608-13. PubMed ID: 1874719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
    Bateman JF; Lamande SR; Dahl HH; Chan D; Mascara T; Cole WG
    J Biol Chem; 1989 Jul; 264(19):10960-4. PubMed ID: 2500431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
    Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
    Lamande SR; Dahl HH; Cole WG; Bateman JF
    J Biol Chem; 1989 Sep; 264(27):15809-12. PubMed ID: 2777764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the alpha2(I) collagen chain.
    Nuytinck L; Wettinck K; Freund M; Van Maldergem L; Fabry G; De Paepe A
    Eur J Hum Genet; 1997; 5(3):161-7. PubMed ID: 9272740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gly85 to Val substitution in pro alpha 1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion.
    Valli M; Zolezzi F; Mottes M; Antoniazzi F; Stanzial F; Tenni R; Pignatti P; Cetta G
    Eur J Biochem; 1993 Oct; 217(1):77-82. PubMed ID: 8223589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
    Vogel BE; Minor RR; Freund M; Prockop DJ
    J Biol Chem; 1987 Oct; 262(30):14737-44. PubMed ID: 3667599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.
    Spotila LD; Constantinou CD; Sereda L; Ganguly A; Riggs BL; Prockop DJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5423-7. PubMed ID: 2052622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
    Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
    Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The substitution of arginine for glycine 85 of the alpha 1(I) procollagen chain results in mild osteogenesis imperfecta. The mutation provides direct evidence for three discrete domains of cooperative melting of intact type I collagen.
    Deak SB; Scholz PM; Amenta PS; Constantinou CD; Levi-Minzi SA; Gonzalez-Lavin L; Mackenzie JW
    J Biol Chem; 1991 Nov; 266(32):21827-32. PubMed ID: 1718984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
    Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
    J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids.
    Grange DK; Gottesman GS; Lewis MB; Marini JC
    Nucleic Acids Res; 1990 Jul; 18(14):4227-36. PubMed ID: 1696002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.